menu
    • menu

    Company profile for Egis Pharmaceuticals PLC

    Egis Pharmaceuticals PLC-PSE
    News
    2024 Hungarian Innovation Grand Prize Contest Kicks Off at Egis

    07 Dec 2024

    // PRESS RELEASE

    Csaba Poroszlai Speaks on Pharma Industry Competitiveness

    29 Nov 2024

    // PRESS RELEASE

    Agreement for Biosimilar in Key Central & Eastern EU Markets

    12 Nov 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Egis Pharmaceuticals

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Related CompaniesRelated Companies

    About

    Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egis’ brand names in 18 countries. In total, the company’s APIs & finished products reach 100 countries. Egis’ focus lies on treating diseases of cardiovascular & central nervous systems; however, it also provides modern treatment solutions in the fields of diabetology, dermatology & wound care. Our research and development activities focus on high-quality, value-added branded generic products. From 2023, Egis offers its CDMO & CMO services as well.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Egis Pharmaceuticals PLCHungary Flag
    Country
    Country
    Hungary
    Address
    Address
    1106 Budapest, Keresztúri út 30-38
    Telephone
    Telephone
    +36 18035555
    Client Email
    Email
    mailbox@egis.hu
    Client Website
    Website
    https://int.egis.health/home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/egis-pharmaceuticals-plc/
    youtube
    YouTube
    http://www.youtube.com/@EgisPharma-rs6qr
    Twitter
    Twitter
    Contact Info
    Others

    FDFs
    fpd.opr@egis.hu
    APIs
    bulk.opr@egis.hu
    Services:
    pharmaservices@egis.hu

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-59944.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-party-content-11093.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    FDF Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-64638.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-79538.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    APIs Under Development 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-98253.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pharma Services

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-party-content-3618.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-45225.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    2024 Hungarian Innovation Grand Prize Contest Kicks Off at Egis
    2024 Hungarian Innovation Grand Prize Contest Kicks Off at Egis

    07 Dec 2024

    // PRESS RELEASE

    https://int.egis.health/a/the-2024-hungarian-innovation-grand-prize-contest-was-announced-at-egis

    PRESS RELEASE
    07 Dec 2024
    Share Share
    Csaba Poroszlai Speaks on Pharma Industry Competitiveness
    Csaba Poroszlai Speaks on Pharma Industry Competitiveness

    29 Nov 2024

    // PRESS RELEASE

    https://int.egis.health/a/csaba-poroszlai-at-the-conference-on-the-competitiveness-of-the-european-and-hungarian-pharmaceutical-industry

    PRESS RELEASE
    29 Nov 2024
    Share Share
    Agreement for Biosimilar in Key Central & Eastern EU Markets
    Agreement for Biosimilar in Key Central & Eastern EU Markets

    12 Nov 2024

    // PRESS RELEASE

    https://int.egis.health/a/agreement-for-biosimilar-candidates-in-key-central-and-eastern-european-markets

    PRESS RELEASE
    12 Nov 2024
    Share Share
    Egis's Celebrates 10-Y Partnership With Kormend Basketball Team
    Egis's Celebrates 10-Y Partnership With Kormend Basketball Team

    19 Oct 2024

    // PRESS RELEASE

    https://int.egis.health/a/ten-years-together-egis-pharmaceuticals-plc-remains-the-partner-of-the-kormend-basketball-team

    PRESS RELEASE
    19 Oct 2024
    Share Share
    Chemistry for Everyone: Cross-Industry Collaboration
    Chemistry for Everyone: Cross-Industry Collaboration

    01 Oct 2024

    // PRESS RELEASE

    https://int.egis.health/a/en-bocy2

    PRESS RELEASE
    01 Oct 2024
    Share Share
    Egis' medicines won the Innovation Grand Prize
    Egis' medicines won the Innovation Grand Prize

    26 Mar 2024

    // PRESS RELEASE

    https://int.egis.health/a/egis-medicines-won-the-innovation-grand-prize

    PRESS RELEASE
    26 Mar 2024
    Share Share

    CEP/COS

    read-more
    read-more

    01

    Allopurinol

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 1996-032 - Rev 05

    Status : Valid

    Issue Date : 2019-08-09

    Type : Chemical

    Substance Number : 576

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Allopurinol, Synthetic route B

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : CEP 2014-364 - Rev 01

    Status : Valid

    Issue Date : 2023-11-27

    Type : Chemical

    Substance Number : 576

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Amlodipine besilate, Synthesis B process...

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : CEP 2023-411 - Rev 00

    Status : Valid

    Issue Date : 2024-06-14

    Type : Chemical

    Substance Number : 1491

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Amlodipine besilate, Synthetic route B

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 2007-185 - Rev 02

    Status : Valid

    Issue Date : 2016-12-19

    Type : Chemical

    Substance Number : 1491

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Aripiprazole

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 2014-252 - Rev 02

    Status : Valid

    Issue Date : 2022-07-21

    Type : Chemical

    Substance Number : 2617

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Bisoprolol fumarate

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R0-CEP 2019-090 - Rev 00

    Status : Valid

    Issue Date : 2021-03-16

    Type : Chemical

    Substance Number : 1710

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Carvedilol

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 2003-042 - Rev 03

    Status : Valid

    Issue Date : 2019-02-20

    Type : Chemical

    Substance Number : 1745

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Carvedilol, Synthetic route B

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 2016-314 - Rev 00

    Status : Valid

    Issue Date : 2023-08-28

    Type : Chemical

    Substance Number : 1745

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Chlorpromazine hydrochloride

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 1996-077 - Rev 07

    Status : Valid

    Issue Date : 2021-10-15

    Type : Chemical

    Substance Number : 475

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Etacrynic Acid

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Certificate Numbers : R1-CEP 2004-053 - Rev 01

    Status : Valid

    Issue Date : 2019-04-16

    Type : Chemical

    Substance Number : 457

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

    Details:

    The formulation contains a eutectic mixture of 7% lidocaine and 7% tetracaine that utilizes phase-changing topical cream Peel technology. In clinical studies, the mean duration of anesthesia has been shown to be in the range of 7 to 9 hours after the application of Pliaglis.


    Lead Product(s): Lidocaine,Tetracaine

    Therapeutic Area: Neurology Brand Name: Pliaglis

    Study Phase: ApprovedProduct Type: Small molecule

    Recipient: Crescita Therapeutics

    Deal Size: Undisclosed Upfront Cash: $0.7 million

    Deal Type: Licensing Agreement December 13, 2021

    Egis Pharmaceuticals

    01

    Egis Pharmaceuticals PLC

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Lead Product(s) : Lidocaine,Tetracaine

    Therapeutic Area : Neurology

    Highest Development Status : Approved

    Recipient : Crescita Therapeutics

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®

    Details : The formulation contains a eutectic mixture of 7% lidocaine and 7% tetracaine that utilizes phase-changing topical cream Peel technology. In clinical studies, the mean duration of anesthesia has been shown to be in the range of 7 to 9 hours after the app...

    Brand Name : Pliaglis

    Molecule Type : Small molecule

    Upfront Cash : $0.7 million

    December 13, 2021

    Egis Pharmaceuticals

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Favipiravir Drug Licenced for Covid-19 Treatment

    Details:

    The active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI).


    Lead Product(s): Favipiravir

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Favipiravir-Generic

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: National Institute of Pharmacy and Nutrition

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable December 20, 2020

    Egis Pharmaceuticals

    02

    Egis Pharmaceuticals PLC

    Hungary
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Lead Product(s) : Favipiravir

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : National Institute of Pharmacy and Nutrition

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Egis Favipiravir Drug Licenced for Covid-19 Treatment

    Details : The active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI).

    Brand Name : Favipiravir-Generic

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    December 20, 2020

    Egis Pharmaceuticals

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    API Manufacturing

    Discover their expertise for : API Manufacturing

    Small Molecules

    read-more
    read-more

    01

    CMO FOR SMALL MOLECULES

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API Manufacturing

    Egis Pharmaceuticals PLC

    From 2023, Egis offers a wide range of small molecule drug substance development and manufacturing services to pharmaceutical partners.

    arrow

    Category : Small Molecules

    Sub Category : Overview

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API Manufacturing

    CMO FOR SMALL MOLECULES

    From 2023, Egis offers a wide range of small molecule drug substance development and manufacturing services to pharmaceutical partners.

    arrow
    CMO for Small Molecules

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    API Development

    read-more
    read-more

    01

    CDMO FOR SMALL MOLECULES

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    Egis Pharmaceuticals PLC

    Egis Pharmaceuticals is a CDMO that offers development and manufacturing services for a variety of small molecule drug substances and intermediates to its pharmaceutical partners.

    arrow

    Category : API Development

    Sub Category : Small Molecules

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    CDMO FOR SMALL MOLECULES

    Egis Pharmaceuticals is a CDMO that offers development and manufacturing services for a variety of small molecule drug substances and intermediates to its pharmaceutical partners.

    arrow
    CDMO for Small Molecules

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    02

    DEV. & MANUFACTURING OF INTERMED...

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    Egis Pharmaceuticals PLC

    Egis Pharmaceuticals is a CDMO which is involved in the chemical process development & manufacturing of intermediates & drug substances from 100 g to 2 kg. It has dedicated analytical laboratories for highly potent (HP) intermediates and drug substances.

    arrow

    Category : API Development

    Sub Category : Fine Chemical / Intermediate

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    DEV. & MANUFACTURING OF INTERMEDIATES & APIs

    Egis Pharmaceuticals is a CDMO which is involved in the chemical process development & manufacturing of intermediates & drug substances from 100 g to 2 kg. It has dedicated analytical laboratories for highly potent (HP) intermediates and drug substances.

    arrow
    Dev. & Manufacturing of Intermediates & APIs

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    03

    CDMO FOR HIGHLY POTENT DRUG SUBS...

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    Egis Pharmaceuticals PLC

    Egis Pharmaceuticals has cutting-edge infrastructure for the contract development of traditional and highly potent (HP) drug substances. It involves the synthesis and scale-up to a maximum 15 L volume with OEB4 classification 1 g/m3 < OEL < 10 g/m3.

    arrow

    Category : API Development

    Sub Category : High Potency APIs (HPAPIs)

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    CDMO FOR HIGHLY POTENT DRUG SUBSTANCES

    Egis Pharmaceuticals has cutting-edge infrastructure for the contract development of traditional and highly potent (HP) drug substances. It involves the synthesis and scale-up to a maximum 15 L volume with OEB4 classification 1 g/m3 < OEL < 10 g/m3.

    arrow
    CDMO for Highly Potent Drug Substances

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    04

    HIGHLY POTENT APIs FOR CLINICAL ...

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    Egis Pharmaceuticals PLC

    Egis Pharmaceuticals is a CDMO that is engaged in highly potent drug substance development and production for clinical trials, formulation experiments, and commercial purposes.

    arrow

    Category : API Development

    Sub Category : Clinical Supply

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    HIGHLY POTENT APIs FOR CLINICAL TRIALS

    Egis Pharmaceuticals is a CDMO that is engaged in highly potent drug substance development and production for clinical trials, formulation experiments, and commercial purposes.

    arrow
    Highly Potent APIs for Clinical Trials

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    05

    API SCALE-UP

    Hungary
    Contact Supplier
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    Egis Pharmaceuticals PLC

    Egis Pharmaceuticals has the capacity to scale up the chemical process development for drug substances and intermediates to a maximum of 20 L volume. It can also develop and scale up highly potent APIs up to 15 L volumes.

    arrow

    Category : API Development

    Sub Category : Scale-Up Capabilities

    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Pharma Service : API & Drug Product Development

    API SCALE-UP

    Egis Pharmaceuticals has the capacity to scale up the chemical process development for drug substances and intermediates to a maximum of 20 L volume. It can also develop and scale up highly potent APIs up to 15 L volumes.

    arrow
    API Scale-Up

    Service
    Web Link

    Capabilities
    #ServicesBio

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY SERVICES

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Egis Pharmaceuticals full-view
    Development of Chemical Intermediates
    full-view
    Small Molecule API Development Services
    full-view
    Intermediates for Anti-Cancer APIs
    full-view

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Contact Egis Pharmaceuticals PLC and get a quotation

    Egis Pharmaceuticals PLC is a supplier offers 48 products (APIs, Excipients or Intermediates).

    Find a price of Allopurinol bulk with CEP, JDMF offered by Egis Pharmaceuticals PLC

    Find a price of Chlorpromazine Hydrochloride bulk with CEP, JDMF offered by Egis Pharmaceuticals PLC

    Find a price of Ethacrynic Acid bulk with DMF, CEP offered by Egis Pharmaceuticals PLC

    Find a price of Promethazine Hydrochloride bulk with DMF, CEP offered by Egis Pharmaceuticals PLC

    Find a price of Allopurinol bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Amlodipine Besylate bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Aripiprazole bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Bisoprolol Fumarate bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Carbidopa bulk with JDMF offered by Egis Pharmaceuticals PLC

    Find a price of Carvedilol bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Levomepromazine Maleate bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Methyldopa bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Nitrendipine bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Quetiapine Hemifumarate bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Ramipril bulk with CEP offered by Egis Pharmaceuticals PLC

    Find a price of Tofisopam bulk with JDMF offered by Egis Pharmaceuticals PLC

    Find a price of Abemaciclib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Abrocitinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Acalabrutinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Alectinib Hydrochloride bulk offered by Egis Pharmaceuticals PLC

    Find a price of Avapritinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Blarcamesine bulk offered by Egis Pharmaceuticals PLC

    Find a price of Clomiphene Citrate bulk offered by Egis Pharmaceuticals PLC

    Find a price of Crotamiton bulk offered by Egis Pharmaceuticals PLC

    Find a price of Dapagliflozin Propanediol Monohydrate bulk offered by Egis Pharmaceuticals PLC

    Find a price of Deucravacitinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Donepezil bulk offered by Egis Pharmaceuticals PLC

    Find a price of Duloxetine Hydrochloride bulk offered by Egis Pharmaceuticals PLC

    Find a price of Empagliflozin bulk offered by Egis Pharmaceuticals PLC

    Find a price of Entrectinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Etrasimod bulk offered by Egis Pharmaceuticals PLC

    Find a price of Fruquintinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Ketoprofen bulk offered by Egis Pharmaceuticals PLC

    Find a price of LCZ 696 bulk offered by Egis Pharmaceuticals PLC

    Find a price of Levocetirizine Dihydrochloride bulk offered by Egis Pharmaceuticals PLC

    Find a price of Nifedipine bulk offered by Egis Pharmaceuticals PLC

    Find a price of Osimertinib Mesylate bulk offered by Egis Pharmaceuticals PLC

    Find a price of Ozanimod Hydrochloride bulk offered by Egis Pharmaceuticals PLC

    Find a price of Palbociclib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Pimavanserin Tartrate bulk offered by Egis Pharmaceuticals PLC

    Find a price of Pregabalin bulk offered by Egis Pharmaceuticals PLC

    Find a price of Resmetirom bulk offered by Egis Pharmaceuticals PLC

    Find a price of Ribociclib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Rivaroxaban bulk offered by Egis Pharmaceuticals PLC

    Find a price of Solriamfetol Hydrochloride bulk offered by Egis Pharmaceuticals PLC

    Find a price of Troriluzole bulk offered by Egis Pharmaceuticals PLC

    Find a price of Upadacitinib bulk offered by Egis Pharmaceuticals PLC

    Find a price of Venetoclax bulk offered by Egis Pharmaceuticals PLC

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search